<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:53:25 -0700</creation_date>
  <update_date>2013-05-27 11:22:17 -0600</update_date>
  <accession>HMDBP01118</accession>
  <secondary_accessions>
    <accession>6411</accession>
    <accession>HMDBP05899</accession>
  </secondary_accessions>
  <protein_type>Unknown</protein_type>
  <synonyms>
    <synonym>IMP 2</synonym>
    <synonym>IMPase 2</synonym>
    <synonym>Inositol-1(or 4)-monophosphatase 2</synonym>
    <synonym>Myo-inositol monophosphatase A2</synonym>
  </synonyms>
  <gene_name>IMPA2</gene_name>
  <general_function>Involved in inositol or phosphatidylinositol phosphatase activity</general_function>
  <specific_function>Can use myo-inositol monophosphates, scylloinositol 1,4-diphosphate, glucose-1-phosphate, beta-glycerophosphate, and 2'-AMP as substrates. Has been implicated as the pharmacological target for lithium Li(+) action in brain.
</specific_function>
  <pathways>
    <pathway>
      <name>myo-inositol biosynthesis</name>
      <smpdb_id/>
      <kegg_map_id/>
    </pathway>
    <pathway>
      <name>Inositol phosphate metabolism</name>
      <smpdb_id/>
      <kegg_map_id>map00562</kegg_map_id>
    </pathway>
    <pathway>
      <name>Phosphatidylinositol signaling system</name>
      <smpdb_id/>
      <kegg_map_id>map04070</kegg_map_id>
    </pathway>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB00547</accession>
      <name>Magnesium</name>
    </metabolite>
    <metabolite>
      <accession>HMDB05949</accession>
      <name>Lithium</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00211</accession>
      <name>Myoinositol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00213</accession>
      <name>Myo-inositol 1-phosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01313</accession>
      <name>D-Myo-inositol 4-phosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01429</accession>
      <name>Phosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02111</accession>
      <name>Water</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02985</accession>
      <name>Inositol phosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06814</accession>
      <name>1D-myo-Inositol 3-phosphate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02142</accession>
      <name>Phosphoric acid</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>catalytic activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hydrolase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>hydrolase activity, acting on ester bonds</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>phosphoric ester hydrolase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>phosphatase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>function</category>
      <description>inositol or phosphatidylinositol phosphatase activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>Cellular component</category>
      <description>cytoplasm</description>
      <go_id>GO:0005737</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>inositol monophosphate 1-phosphatase activity</description>
      <go_id>GO:0008934</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>inositol monophosphate 3-phosphatase activity</description>
      <go_id>GO:0052832</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>inositol monophosphate 4-phosphatase activity</description>
      <go_id>GO:0052833</go_id>
    </go_class>
    <go_class>
      <category>Molecular function</category>
      <description>metal ion binding</description>
      <go_id>GO:0046872</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>inositol biosynthetic process</description>
      <go_id>GO:0006021</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>inositol phosphate dephosphorylation</description>
      <go_id>GO:0046855</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>phosphatidylinositol phosphorylation</description>
      <go_id>GO:0046854</go_id>
    </go_class>
    <go_class>
      <category>Biological process</category>
      <description>signal transduction</description>
      <go_id>GO:0007165</go_id>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Cytoplasmic</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>18</chromosome_location>
    <locus>18p11.2</locus>
    <gene_sequence>&gt;867 bp
ATGAAGCCGAGCGGCGAGGACCAGGCGGCGCTGGCGGCCGGCCCCTGGGAGGAGTGCTTC
CAGGCGGCCGTGCAGCTGGCGCTGCGGGCAGGACAGATCATCAGAAAAGCCCTTACTGAG
GAAAAACGTGTCTCAACAAAAACATCAGCTGCAGATCTTGTGACAGAAACAGATCACCTT
GTGGAAGATTTAATTATTTCTGAGTTGCGAGAGAGGTTTCCTTCACACAGGTTCATTGCA
GAAGAGGCCGCGGCTTCTGGGGCCAAGTGTGTGCTCACCCACAGCCCGACGTGGATCATC
GACCCCATCGACGGCACCTGCAATTTTGTGCACAGATTCCCGACTGTGGCGGTTAGCATT
GGATTTGCTGTTCGACAAGAGCTTGAATTCGGAGTGATTTACCACTGCACAGAGGAGCGG
CTGTACACGGGCCGGCGGGGTCGGGGCGCCTTCTGCAATGGCCAGCGGCTCCGGGTCTCC
GGGGAGACAGATCTCTCAAAGGCCTTGGTTCTGACAGAAATTGGCCCCAAACGTGACCCT
GCGACCCTGAAGCTGTTCCTGAGTAACATGGAGCGGCTGCTGCATGCCAAGGCGCATGGG
GTCCGAGTGATTGGAAGCTCCACATTGGCACTCTGCCACCTGGCCTCAGGGGCCGCGGAT
GCCTATTACCAGTTTGGCCTGCACTGCTGGGATCTGGCGGCTGCCACAGTCATCATCAGA
GAAGCAGGCGGCATCGTGATAGACACTTCGGGTGGACCCCTCGACCTCATGGCTTGCAGA
GTGGTTGCGGCCAGCACCCGGGAGATGGCGATGCTCATAGCTCAGGCCTTACAGACCATT
AACTATGGGCGGGATGATGAGAAGTGA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>288</residue_number>
    <molecular_weight>31320.525</molecular_weight>
    <theoretical_pi>6.61</theoretical_pi>
    <pfams>
      <pfam>
        <name>Inositol_P</name>
        <pfam_id>PF00459</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
    </transmembrane_regions>
    <signal_regions>
    </signal_regions>
    <protein_sequence>&gt;Inositol monophosphatase 2
MKPSGEDQAALAAGPWEECFQAAVQLALRAGQIIRKALTEEKRVSTKTSAADLVTETDHL
VEDLIISELRERFPSHRFIAEEAAASGAKCVLTHSPTWIIDPIDGTCNFVHRFPTVAVSI
GFAVRQELEFGVIYHCTEERLYTGRRGRGAFCNGQRLRVSGETDLSKALVLTEIGPKRDP
ATLKLFLSNMERLLHAKAHGVRVIGSSTLALCHLASGAADAYYQFGLHCWDLAAATVIIR
EAGGIVIDTSGGPLDLMACRVVAASTREMAMLIAQALQTINYGRDDEK</protein_sequence>
  </protein_properties>
  <genbank_protein_id>2406666</genbank_protein_id>
  <uniprot_id>O14732</uniprot_id>
  <uniprot_name>IMPA2_HUMAN</uniprot_name>
  <pdb_ids>
    <pdb_id>2CZH</pdb_id>
    <pdb_id>2CZI</pdb_id>
    <pdb_id>2CZK</pdb_id>
    <pdb_id>2DDK</pdb_id>
    <pdb_id>2FVZ</pdb_id>
  </pdb_ids>
  <genbank_gene_id>AF014398</genbank_gene_id>
  <genecard_id>IMPA2</genecard_id>
  <geneatlas_id>IMPA2</geneatlas_id>
  <hgnc_id>HGNC:6051</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Yoshikawa T, Turner G, Esterling LE, Sanders AR, Detera-Wadleigh SD: A novel human myo-inositol monophosphatase gene, IMP.18p, maps to a susceptibility region for bipolar disorder. Mol Psychiatry. 1997 Sep;2(5):393-7.</reference_text>
      <pubmed_id>9322233</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sjoholt G, Gulbrandsen AK, Lovlie R, Berle JO, Molven A, Steen VM: A human myo-inositol monophosphatase gene (IMPA2) localized in a putative susceptibility region for bipolar disorder on chromosome 18p11.2: genomic structure and polymorphism screening in manic-depressive patients. Mol Psychiatry. 2000 Mar;5(2):172-80.</reference_text>
      <pubmed_id>10822345</pubmed_id>
    </reference>
    <reference>
      <reference_text>Gerhard DS, Wagner L, Feingold EA, Shenmen CM, Grouse LH, Schuler G, Klein SL, Old S, Rasooly R, Good P, Guyer M, Peck AM, Derge JG, Lipman D, Collins FS, Jang W, Sherry S, Feolo M, Misquitta L, Lee E, Rotmistrovsky K, Greenhut SF, Schaefer CF, Buetow K, Bonner TI, Haussler D, Kent J, Kiekhaus M, Furey T, Brent M, Prange C, Schreiber K, Shapiro N, Bhat NK, Hopkins RF, Hsie F, Driscoll T, Soares MB, Casavant TL, Scheetz TE, Brown-stein MJ, Usdin TB, Toshiyuki S, Carninci P, Piao Y, Dudekula DB, Ko MS, Kawakami K, Suzuki Y, Sugano S, Gruber CE, Smith MR, Simmons B, Moore T, Waterman R, Johnson SL, Ruan Y, Wei CL, Mathavan S, Gunaratne PH, Wu J, Garcia AM, Hulyk SW, Fuh E, Yuan Y, Sneed A, Kowis C, Hodgson A, Muzny DM, McPherson J, Gibbs RA, Fahey J, Helton E, Ketteman M, Madan A, Rodrigues S, Sanchez A, Whiting M, Madari A, Young AC, Wetherby KD, Granite SJ, Kwong PN, Brinkley CP, Pearson RL, Bouffard GG, Blakesly RW, Green ED, Dickson MC, Rodriguez AC, Grimwood J, Schmutz J, Myers RM, Butterfield YS, Griffith M, Griffith OL, Krzywinski MI, Liao N, Morin R, Palmquist D, Petrescu AS, Skalska U, Smailus DE, Stott JM, Schnerch A, Schein JE, Jones SJ, Holt RA, Baross A, Marra MA, Clifton S, Makowski KA, Bosak S, Malek J: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). Genome Res. 2004 Oct;14(10B):2121-7.</reference_text>
      <pubmed_id>15489334</pubmed_id>
    </reference>
    <reference>
      <reference_text>Seelan RS, Parthasarathy LK, Parthasarathy RN: Lithium modulation of the human inositol monophosphatase 2 (IMPA2) promoter. Biochem Biophys Res Commun. 2004 Nov 26;324(4):1370-8.</reference_text>
      <pubmed_id>15504365</pubmed_id>
    </reference>
    <reference>
      <reference_text>Ohnishi T, Ohba H, Seo KC, Im J, Sato Y, Iwayama Y, Furuichi T, Chung SK, Yoshikawa T: Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1. J Biol Chem. 2007 Jan 5;282(1):637-46. Epub 2006 Oct 26.</reference_text>
      <pubmed_id>17068342</pubmed_id>
    </reference>
    <reference>
      <reference_text>Arai R, Ito K, Ohnishi T, Ohba H, Akasaka R, Bessho Y, Hanawa-Suetsugu K, Yoshikawa T, Shirouzu M, Yokoyama S: Crystal structure of human myo-inositol monophosphatase 2, the product of the putative susceptibility gene for bipolar disorder, schizophrenia, and febrile seizures. Proteins. 2007 May 15;67(3):732-42.</reference_text>
      <pubmed_id>17340635</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>Lithium</name>
        <accession>HMDB05949</accession>
      </metabolite>
      <reference>
        <reference_text>Cryns K, Shamir A, Shapiro J, Daneels G, Goris I, Van Craenendonck H, Straetemans R, Belmaker RH, Agam G, Moechars D, Steckler T: Lack of lithium-like behavioral and molecular effects in IMPA2 knockout mice.  Neuropsychopharmacology. 2007 Apr;32(4):881-91. Epub 2006 Jul 12.</reference_text>
        <pubmed_id>16841073</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Lithium</name>
        <accession>HMDB05949</accession>
      </metabolite>
      <reference>
        <reference_text>Ohnishi T, Ohba H, Seo KC, Im J, Sato Y, Iwayama Y, Furuichi T, Chung SK, Yoshikawa T: Spatial expression patterns and biochemical properties distinguish a second myo-inositol monophosphatase IMPA2 from IMPA1. J Biol Chem. 2007 Jan 5;282(1):637-46. Epub 2006 Oct 26.</reference_text>
        <pubmed_id>17068342</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Lithium</name>
        <accession>HMDB05949</accession>
      </metabolite>
      <reference>
        <reference_text>Ohnishi T, Yamada K, Ohba H, Iwayama Y, Toyota T, Hattori E, Inada T, Kunugi H, Tatsumi M, Ozaki N, Iwata N, Sakamoto K, Iijima Y, Iwata Y, Tsuchiya KJ, Sugihara G, Nanko S, Osumi N, Detera-Wadleigh SD, Kato T, Yoshikawa T: A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription. Neuropsychopharmacology. 2007 Aug;32(8):1727-37. Epub 2007 Jan 24.</reference_text>
        <pubmed_id>17251911</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
